Bath & Body Works (NYSE:BBWI - Get Free Report) was downgraded by research analysts at Barclays from an "equal weight" rating to an "underweight" rating in a research note issued on Friday,Briefing.com Automated Import reports. They presently have a $28.00 price target on the stock, down from their prior price target of $31.00. Barclays's target price would suggest a potential downside of 11.76% from the company's previous close.
A number of other equities analysts have also commented on the stock. Bank of America cut their price objective on shares of Bath & Body Works from $54.00 to $45.00 and set a "buy" rating on the stock in a report on Thursday, August 29th. UBS Group cut their price objective on shares of Bath & Body Works from $52.00 to $38.00 and set a "neutral" rating on the stock in a report on Thursday, August 29th. Morgan Stanley dropped their target price on shares of Bath & Body Works from $56.00 to $51.00 and set an "overweight" rating for the company in a research report on Thursday, September 5th. Piper Sandler dropped their target price on shares of Bath & Body Works from $47.00 to $39.00 and set a "neutral" rating for the company in a research report on Thursday, July 11th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Bath & Body Works from $42.00 to $39.00 and set a "neutral" rating for the company in a research report on Thursday, August 29th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and nine have issued a buy rating to the company's stock. Based on data from MarketBeat, Bath & Body Works presently has a consensus rating of "Moderate Buy" and an average target price of $42.44.
Get Our Latest Report on Bath & Body Works
Shares of BBWI opened at $31.73 on Friday. The firm has a market cap of $6.95 billion, a PE ratio of 7.68, a price-to-earnings-growth ratio of 0.99 and a beta of 1.79. The company's fifty day moving average is $30.02 and its two-hundred day moving average is $37.08. Bath & Body Works has a fifty-two week low of $26.20 and a fifty-two week high of $52.99.
Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.02. The business had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.54 billion. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. As a group, equities research analysts anticipate that Bath & Body Works will post 3.18 earnings per share for the current year.
In related news, CEO Gina Boswell purchased 6,000 shares of Bath & Body Works stock in a transaction dated Wednesday, October 9th. The stock was bought at an average cost of $29.64 per share, with a total value of $177,840.00. Following the purchase, the chief executive officer now owns 242,987 shares in the company, valued at approximately $7,202,134.68. The trade was a 0.00 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.27% of the company's stock.
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. First Community Trust NA acquired a new stake in Bath & Body Works during the second quarter valued at approximately $30,000. Livforsakringsbolaget Skandia Omsesidigt raised its holdings in shares of Bath & Body Works by 300.0% during the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company's stock valued at $38,000 after acquiring an additional 900 shares during the period. EntryPoint Capital LLC raised its holdings in shares of Bath & Body Works by 224.0% during the first quarter. EntryPoint Capital LLC now owns 1,471 shares of the company's stock valued at $74,000 after acquiring an additional 1,017 shares during the period. Meeder Asset Management Inc. raised its holdings in shares of Bath & Body Works by 480.3% during the third quarter. Meeder Asset Management Inc. now owns 1,735 shares of the company's stock valued at $55,000 after acquiring an additional 1,436 shares during the period. Finally, GAMMA Investing LLC raised its holdings in shares of Bath & Body Works by 65.4% during the second quarter. GAMMA Investing LLC now owns 1,846 shares of the company's stock valued at $72,000 after acquiring an additional 730 shares during the period. 95.14% of the stock is owned by institutional investors and hedge funds.
Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.